202 related articles for article (PubMed ID: 32580685)
1. Species distribution and antifungal susceptibilities of bloodstream
Brescini L; Mazzanti S; Orsetti E; Morroni G; Masucci A; Pocognoli A; Barchiesi F
J Chemother; 2020 Sep; 32(5):244-250. PubMed ID: 32580685
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
[TBL] [Abstract][Full Text] [Related]
5. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Iatta R; Caggiano G; Cuna T; Montagna MT
J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.
Tan TY; Hsu LY; Alejandria MM; Chaiwarith R; Chinniah T; Chayakulkeeree M; Choudhury S; Chen YH; Shin JH; Kiratisin P; Mendoza M; Prabhu K; Supparatpinyo K; Tan AL; Phan XT; Tran TT; Nguyen GB; Doan MP; Huynh VA; Nguyen SM; Tran TB; Van Pham H
Med Mycol; 2016 Jul; 54(5):471-7. PubMed ID: 26868904
[TBL] [Abstract][Full Text] [Related]
8. The emergence of non-albicans candidemia and evaluation of HiChrome Candida differential agar and VITEK2 YST® platform for differentiation of Candida bloodstream isolates in teaching hospital Kandy, Sri Lanka.
Kothalawala M; Jayaweera JAAS; Arunan S; Jayathilake A
BMC Microbiol; 2019 Jun; 19(1):136. PubMed ID: 31226938
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.
Bassetti M; Merelli M; Righi E; Diaz-Martin A; Rosello EM; Luzzati R; Parra A; Trecarichi EM; Sanguinetti M; Posteraro B; Garnacho-Montero J; Sartor A; Rello J; Tumbarello M
J Clin Microbiol; 2013 Dec; 51(12):4167-72. PubMed ID: 24108614
[TBL] [Abstract][Full Text] [Related]
10. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex.
Barchiesi F; Orsetti E; Osimani P; Catassi C; Santelli F; Manso E
BMC Infect Dis; 2016 Aug; 16():387. PubMed ID: 27507170
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
Chen YC; Kuo SF; Chen FJ; Lee CH
Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
[TBL] [Abstract][Full Text] [Related]
13. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
15. Impact on Antifungal Susceptibility Patterns of Previous vs. Revised Clinical and Laboratory Standards Institute Breakpoints for Candida Species Isolated from Candidemia: Experience of Two Tertiary Care Institutions in Japan.
Hirano R; Minakawa S; Kitazawa J; Saito N; Kayaba H
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307163
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia.
Falces-Romero I; Romero-Gómez MP; Moreno-Ramos F; Mingorance J; García-Rodríguez J; Cendejas-Bueno E
Med Mycol; 2021 Apr; 59(4):350-354. PubMed ID: 32634233
[TBL] [Abstract][Full Text] [Related]
17. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
[TBL] [Abstract][Full Text] [Related]
18. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.
Chen PL; Lo HJ; Wu CJ; Lee HC; Chang CM; Lee NY; Wang AH; Lin WL; Ko NY; Lee CC; Ko WC
Mycoses; 2011 Jul; 54(4):e17-23. PubMed ID: 20028463
[TBL] [Abstract][Full Text] [Related]
19. Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece.
Spiliopoulou A; Vamvakopoulou S; Bartzavali C; Dimitracopoulos G; Anastassiou ED; Christofidou M
Clin Microbiol Infect; 2010 Sep; 16(9):1378-81. PubMed ID: 20156217
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]